Re: Chickenpox vaccination

[Guest guest]

Here is my personal take on the chicken pox vaccine. Chicken pox is not the

biggest of things for a parent to worry about. They are little, red, itchy

bumps that annoy the heck out of your child. Sure, they are highly

contagious...but so what? So is the common cold. I think it's just another

useless vaccine. Besides, there hasn't been any actual proof that the

children given this vaccine won't get the chicken pox later in life...when it

becomes shingles. I'd rather have my kid get chicken pox when someone at

school has than have my son or daughter get shingles at 35 or 40. That's

just my opinion. The only vaccines my daughter is receiving are the MMR,

Polio, and DTP. She won't be getting her booster MMR but she will receive

the booster Tetanus. But, that's me. At any rate, do more research before

you commit...that's always the best answer.

Jo

[Guest guest]

In a message dated 5/18/00 2:50:40 PM Eastern Daylight Time,

purpleturtle51@... writes:

> They say

> that after 12 if you child hasn't had it naturally,

> that's when they enter the age where getting

> chickenpox can be very serious.

Hello!

I was 15 when I got the chicken pox. While I was covered head-to-toe in

the itchy blisters, I was only left with 3 small scars that only I notice. I

gave it to my brother (13yrs.), my boyfriend at the time(15yrs.old), his

sister (14yrs.) and their mother (30-something). We all came through it just

fine, although the mother obviously had a much harder time with it.

Definitely give it a few more years before giving your child this vax.

Give him a chance to develop natural, lifetime-lasting immunity. The truth

is the only way that they can rationalize this shot is through talk of " lost

wages " for parents and " time missed from school " for kids- there is no true

health threat for a healthy child (or teen).

Here's some links...look into all this for yourself! Good luck!

<A HREF= " http://www.whaleto.freeserve.co.uk/ " >WHALE</A> (yes this is a site

about vax, not whales! LOL)

<A HREF= " http://www.909shot.com/ " >National Vaccine Information Center</A>

<A HREF= " http://www.access1.net/Via/ " >VACCINE INFORMATION & AWARENESS</A>

<A HREF= " http://home.sprynet.com/~noshots/index.htm " >Welcome to the

Concerned Parents for Vaccine Safety</A>

*i'll repost if the links don't work*

~Cheryl~

[Guest guest]

--- JustMOMThanks@... wrote:

> Here is my personal take on the chicken pox vaccine.

> Chicken pox is not the

> biggest of things for a parent to worry about. They

> are little, red, itchy

> bumps that annoy the heck out of your child. Sure,

> they are highly

> contagious...but so what? So is the common cold. I

> think it's just another

> useless vaccine. Besides, there hasn't been any

> actual proof that the

> children given this vaccine won't get the chicken

> pox later in life...when it

> becomes shingles. I'd rather have my kid get

> chicken pox when someone at

> school has than have my son or daughter get shingles

> at 35 or 40. That's

> just my opinion. The only vaccines my daughter is

> receiving are the MMR,

> Polio, and DTP. She won't be getting her booster

> MMR but she will receive

> the booster Tetanus. But, that's me. At any rate,

> do more research before

> you commit...that's always the best answer.

>

> Jo

Hi Jo,

Thanks so much for your reply! I pretty much agree

with you on the chickenpox vaccination but this is the

reason I think my child should get it. My child just

turned 13 and has never had the chickenpox. They say

that after 12 if you child hasn't had it naturally,

that's when they enter the age where getting

chickenpox can be very serious. I've read that now in

two places. That scares me! So I don't know what to

do. My md encourages my child to get it, for whatever

that is worth. I tend to agree with you that it is

just another useless vaccination especially when I

found out it was originally developed for children

with leukemina (sp?) and problems with immune system.

If chickenpox was such a bad thing then why wasn't the

shot developed for everyone. You know what I'm

saying. Did you find any useful information on this

shot that helped you to come to you decision. Please

let me know.

Thanks,

Gail

>

__________________________________________________

[Guest guest]

Here is the package insert for the Chickenpox Vaccine. This was studied for

such a short time. I think there is more harm to be done by getting this

shot, then by not, especially in a 13 year old. This is long, but if you

scroll down you will see the adverse reactions as well as other good

information. Good luck with your decision. -Dawn

PDR® entry for

Varivax (Merck)

Description Actions Indications Contraindications Warnings Precautions Drug

Interactions Adverse Reactions Dosage and Administration How Supplied

DESCRIPTION

VARIVAX* [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the

Oka/Merck strain of live, attenuated varicella virus. The virus was

initially obtained from a child with natural varicella, then introduced into

human embryonic lung cell cultures, adapted to and propagated in embryonic

guinea pig cell cultures and finally propagated in human diploid cell

cultures (WI-38). Further passage of the virus for varicella vaccine was

performed at Merck Research Laboratories (MRL) in human diploid cell

cultures (MRC-5) that were free of adventitious agents. This live,

attenuated varicella vaccine is a lyophilized preparation containing

sucrose, phosphate, glutamate, and processed gelatin as stabilizers.

VARIVAX, when reconstituted as directed, is a sterile preparation for

subcutaneous administration. Each 0.5 mL dose contains the following: a

minimum of 1350 PFU (plaque forming units) of Oka/Merck varicella virus when

reconstituted and stored at room temperature for 30 minutes, approximately

25 mg of sucrose, 12.5 mg hydrolyzed gelatin, 3.2 mg sodium chloride, 0.5 mg

monosodium L-glutamate, 0.45 mg of sodium phosphate dibasic, 0.08 mg of

potassium phosphate monobasic, 0.08 mg of potassium chloride; residual

components of MRC-5 cells including DNA and protein; and trace quantities of

sodium phosphate monobasic, EDTA, neomycin, and fetal bovine serum. The

product contains no preservative.

To maintain potency, the lyophilized vaccine must be kept frozen at an

average temperature of -15°C (+5°F) or colder and must be used before the

expiration date (see HOW SUPPLIED , Stability and Storage ). Storage in any

freezer (e.g., chest, frost-free) that reliably maintains an average

temperature of -15°C (+5°F) or colder and has a separate sealed freezer door

is acceptable.

----------------------------------------------------------------------------

----

*Registered trademark of MERCK & CO., Inc.

(back to top)

CLINICAL PHARMACOLOGY

Varicella is a highly communicable disease in children, adolescents, and

adults caused by the varicella-zoster virus. The disease usually consists of

300 to 500 maculopapular and/or vesicular lesions accompanied by a fever

(oral temperature >/=100°F) in up to 70% of individuals. Approximately 3.5

million cases of varicella occurred annually from 1980-1994 in the United

States with the peak incidence occurring in children five to nine years of

age. The incidence rate of chickenpox is 8.3-9.1% per year in children 1-9

years of age. The attack rate of natural varicella following household

exposure among healthy susceptible children was shown to be 87%. Although it

is generally a benign, self-limiting disease, varicella may be associated

with serious complications (e.g., bacterial superinfection, pneumonia,

encephalitis, Reye's Syndrome), and/or death.

Evaluation of Clinical Efficacy Afforded by VARIVAX

Clinical Data in Children

In combined clinical trials of VARIVAX at doses ranging from 1,000-17,000

PFU, the majority of subjects who received VARIVAX and were exposed to

wild-type virus were either completely protected from chickenpox or

developed a milder form (for clinical description see below) of the disease.

The protective efficacy of VARIVAX was evaluated in three different ways: 1)

by comparing chickenpox rates in vaccinees versus historical controls, 2) by

assessment of protection from disease following household exposure, and 3)

by a placebo-controlled, double-blind clinical trial.

In early clinical trials, a total of 4142 children received 1000-1625 PFU of

attenuated virus per dose of VARIVAX and have been followed for up to six

years post single-dose vaccination. In this group there was considerable

variation in chickenpox rates among studies and study sites, and much of the

reported data were acquired by passive follow-up. It was observed that

2.1%-3.6% of vaccinees per year reported chickenpox (called breakthrough

cases). This represents an approximate 67% (57-77%) decrease from the total

number of cases expected based on attack rates in children aged 1-9 over

this same period (8.3-9.1%). In those who developed breakthrough chickenpox

postvaccination, the majority experienced mild disease (median number of

lesions <50). In one study, a total of 47% (27/58) of breakthrough cases had

<50 lesions compared with 8% (7/92) in unvaccinated individuals, and 7%

(4/58) of breakthrough cases had >300 lesions compared with 50% (46/92) in

unvaccinated individuals. In studies of vaccinated children who contracted

chickenpox after a household exposure, 57% (31/54) of the cases reported <50

lesions, while 1.9% (1/54) reported >300 lesions with an oral temperature

above 100°F.

In later clinical trials with the current vaccine, a total of 1164 children

received 2900-9000 PFU of attenuated virus per dose of VARIVAX and have been

followed for up to three years post single-dose vaccination. It was observed

that 0.2%-1.0% of vaccinees per year reported breakthrough chickenpox for up

to three years post single-dose vaccination. This represents an approximate

93% decrease from the total number of cases expected based on attack rates

in children aged 1-9 over this same period (8.3%-9.1%). In those who

developed breakthrough chickenpox postvaccination, the majority experienced

mild disease.

Among a subset of vaccinees who were actively followed, 259 were exposed to

an individual with chickenpox in a household setting. There were no reports

of breakthrough chickenpox in 80% of exposed children; 20% reported a mild

form of chickenpox. This represents a 77% reduction in the expected number

of cases when compared to the historical attack rate of varicella following

household exposure to chickenpox of 87% in unvaccinated individuals.

Although no placebo-controlled trial was carried out with VARIVAX using the

current vaccine, a placebo-controlled trial was conducted using a

formulation containing 17,000 PFU per dose. In this trial, a single dose of

VARIVAX protected 96-100% of children against chickenpox over a two-year

period. The study enrolled healthy individuals 1 to 14 years of age (n=491

vaccine, n=465 placebo). In the first year, 8.5% of placebo recipients

contracted chickenpox, while no vaccine recipient did, for a calculated

protection rate of 100% during the first varicella season. In the second

year, when only a subset of individuals agreed to remain in the blinded

study (n=163 vaccine, n=161 placebo), 96% protective efficacy was calculated

for the vaccine group as compared to placebo.

There are insufficient data to assess the rate of protection against the

complications of chickenpox (e.g., encephalitis, hepatitis, pneumonia) in

children.

Clinical Data in Adolescents and Adults

Although no placebo-controlled trial was carried out in adolescents and

adults, efficacy was determined by evaluation of protection when vaccinees

received 2 doses of VARIVAX 4 or 8 weeks apart and were subsequently exposed

to chickenpox in a household setting. In up to two years of active

follow-up, 17 of 64 (27%) vaccinees reported breakthrough chickenpox

following household exposure; of the 17 cases, 12 (71%) reported <50

lesions, 5 reported 50-300 lesions, and none reported >300 lesions with an

oral temperature above 100°F. In combined clinical studies of adolescents

and adults (n=1019) who received two doses of VARIVAX and later developed

breakthrough chickenpox and reported numbers of lesions (42 of 1019), 25 of

42 (60%) reported <50 lesions, 16 of 42 (38%) reported 50-300 lesions, and 1

of 42 (2%) reported >300 lesions and an oral temperature above 100°F.

The attack rate of unvaccinated adults exposed to a single contact in a

household has not been previously studied. When compared to the previously

reported attack rate of natural varicella of 87% following household

exposure among unvaccinated children, this represents an approximate 70%

reduction in the expected number of cases in the household setting.

There are insufficient data to assess the rate of protection of VARIVAX

against the serious complications of chickenpox in adults (e.g.,

encephalitis, hepatitis, pneumonitis) and during pregnancy (congenital

varicella syndrome).

Immunogenicity of VARIVAX

Clinical trials with several formulations of the vaccine containing

attenuated virus ranging from 1000 to 17,000 PFU per dose have demonstrated

that VARIVAX induces detectable immune responses in a high proportion of

individuals and is generally well tolerated in healthy individuals ranging

from 12 months to 55 years of age.

Seroconversion as defined by the acquisition of any detectable varicella

antibodies (gpELISA >0.3, a highly sensitive assay which is not commercially

available) was observed in 97% of vaccinees at approximately 4-6 weeks

postvaccination in 6889 susceptible children 12 months to 12 years of age.

Rates of breakthrough disease were significantly lower among children with

varicella antibody titers >/=5 compared to children with titers <5. Titers

>/=5 were induced in approximately 76% of children vaccinated with a single

dose of vaccine at 1000-17,000 PFU per dose. In a multicenter study

involving susceptible adolescents and adults 13 years of age and older, two

doses of VARIVAX administered four to eight weeks apart induced a

seroconversion rate (gpELISA >0.3) of approximately 75% in 539 individuals

four weeks after the first dose and of 99% in 479 individuals four weeks

after the second dose. The average antibody response in vaccinees who

received the second dose eight weeks after the first dose was higher than

that in those, who received the second dose four weeks after the first dose.

In another multicenter study involving adolescents and adults, two doses of

VARIVAX administered eight weeks apart induced a seroconversion rate

(gpELISA >0.3) of 94% in 142 individuals six weeks after the first dose and

99% in 122 individuals six weeks after the second dose.

VARIVAX also induces cell-mediated immune responses in vaccinees. The

relative contributions of humoral immunity and cell-mediated immunity to

protection from chickenpox are unknown.

Persistence of Immune Response

Studies in vaccinees examining chickenpox breakthrough rates over 5 years

showed the lowest rates (0.2-2.9%) in the first two years postvaccination,

with somewhat higher but stable rates in the third through fifth year. The

severity of reported breakthrough chickenpox, as measured by number of

lesions and maximum temperature, appeared not to increase with time since

vaccination.

In clinical studies involving healthy children who received 1 dose of

vaccine, detectable varicella antibodies (gpELISA >0.3) were present in

98.8% (3775/3822) at 1 year, 98.9% (1057/1069) at 2 years, 97.5% (548/562)

at 3 years, and 99.5% (220/221) at 4 years postvaccination. Antibody levels

were present at least one year in 97.2% (423/435) of healthy adolescents and

adults who received two doses of live varicella vaccine separated by 4 to 8

weeks. A boost in antibody levels has been observed in vaccinees following

exposure to natural varicella which could account for the apparent long-term

persistence of antibody levels after vaccination in these studies. The

duration of protection from varicella obtained using VARIVAX in the absence

of wild-type boosting is unknown. VARIVAX also induces cell-mediated immune

responses in vaccinees. The relative contributions of humoral immunity and

cell-mediated immunity to protection from chickenpox are unknown.

Transmission

In the placebo-controlled trial, transmission of vaccine virus was assessed

in household settings (during the 8-week postvaccination period) in 416

susceptible placebo recipients who were household contacts of 445 vaccine

recipients. Of the 416 placebo recipients, three developed chickenpox and

seroconverted, nine reported a varicella-like rash and did not seroconvert,

and six had no rash but seroconverted. If vaccine virus transmission

occurred, it did so at a very low rate and possibly without recognizable

clinical disease in contacts. These cases may represent either natural

varicella from community contacts or a low incidence of transmission of

vaccine virus from vaccinated contacts (see PRECAUTIONS, Transmission ).

Post-marketing experience suggests that transmission of vaccine virus may

occur rarely between healthy vaccinees who develop a varicella-like rash and

healthy susceptible contacts. Transmission of vaccine virus from vaccinees

without a varicella-like rash has been reported but has not been confirmed.

Herpes Zoster

Overall, 9454 healthy children (12 months to 12 years of age) and 1648

adolescents and adults (13 years of age and older) have been vaccinated with

Oka/Merck live attenuated varicella vaccine in clinical trials. Eight cases

of herpes zoster have been reported in children during 42,556 person years

of follow-up in clinical trials, resulting in a calculated incidence of at

least 18.8 cases per 100,000 person years. The completeness of this

reporting has not been determined. One case of herpes zoster has been

reported in the adolescent and adult age group during 5410 person years of

follow-up in clinical trials resulting in a calculated incidence of 18.5

cases per 100,000 person years.

All nine cases were mild and without sequelae. Two cultures (one child and

one adult) obtained from vesicles were positive for wild-type varicella

zoster virus as confirmed by restriction endonuclease analysis. The

long-term effect of VARIVAX on the incidence of herpes zoster, particularly

in those vaccinees exposed to natural varicella, is unknown at present.

In children, the reported rate of zoster in vaccine recipients appears not

to exceed that previously determined in a population-based study of healthy

children who had experienced natural varicella. The incidence of zoster in

adults who have had natural varicella infection is higher than that in

children.

Reye's Syndrome

Reye's Syndrome has occurred in children and adolescents following natural

varicella infection, the majority of whom had received salicylates. In

clinical studies in healthy children and adolescents in the United States,

physicians advised varicella vaccine recipients not to use salicylates for

six weeks after vaccination. There were no reports of Reye's Syndrome in

varicella vaccine recipients during these studies.

Studies with Other Vaccines

In combined clinical studies involving 1080 children 12 to 36 months of age,

653 received VARIVAX and M-M-R*II (Measles, Mumps, and Rubella Virus Vaccine

Live) concomitantly at separate sites and 427 received the vaccines six

weeks apart. Seroconversion rates and antibody levels were comparable

between the two groups at approximately six weeks postvaccination to each of

the virus vaccine components. No differences were noted in adverse reactions

reported in those who received VARIVAX concomitantly with M-M-R II (Measles,

Mumps, and Rubella Virus Vaccine Live) at separate sites and those who

received VARIVAX and M-M-R II (Measles, Mumps, and Rubella Virus Vaccine

Live) at different times (see PRECAUTIONS , Drug Interactions , Use with

Other Vaccines ).

In a clinical study involving 318 children 12 months to 42 months of age,

160 received an investigational vaccine (a formulation combining measles,

mumps, rubella, and varicella in one syringe) concomitantly with booster

doses of DTaP (diphtheria, tetanus, acellular pertussis) and OPV (oral

poliovirus vaccine) while 144 received M-M-R II (Measles, Mumps, and Rubella

Virus Vaccine Live) concomitantly with booster doses of DTaP and OPV

followed by VARIVAX 6 weeks later. At six weeks postvaccination,

seroconversion rates for measles, mumps, rubella, and varicella and the

percentage of vaccinees whose titers were boosted for diphtheria, tetanus,

pertussis, and polio were comparable between the two groups, but

anti-varicella levels were decreased when the investigational vaccine

containing varicella was administered concomitantly with DTaP. No clinically

significant differences were noted in adverse reactions between the two

groups.

In another clinical study involving 307 children 12 to 18 months of age, 150

received an investigational vaccine (a formulation combining measles, mumps,

rubella, and varicella in one syringe) concomitantly with a booster dose of

PedvaxHIB* [Haemophilus b Conjugate Vaccine (Meningococcal Protein

Conjugate)] while 130 received M-M-R II (Measles, Mumps, and Rubella Virus

Vaccine Live) concomitantly with a booster dose of PedvaxHIB followed by

VARIVAX 6 weeks later. At six weeks postvaccination, seroconversion rates

for measles, mumps, rubella, and varicella, and geometric mean titers for

PedvaxHIB were comparable between the two groups, but anti-varicella levels

were decreased when the investigational vaccine containing varicella was

administered concomitantly with PedvaxHIB. No clinically significant

differences in adverse reactions were seen between the two groups.

VARIVAX is recommended for subcutaneous administration. However, during

clinical trials, some children received VARIVAX intramuscularly resulting in

seroconversion rates similar to those in children who received the vaccine

by the subcutaneous route. Persistence of antibody and efficacy in those

receiving intramuscular injections have not been defined.

----------------------------------------------------------------------------

----

* Registered trademark of MERCK & Co., Inc.

(back to top)

INDICATIONS AND USAGE

VARIVAX is indicated for vaccination against varicella in individuals 12

months of age and older.

Revaccination

The duration of protection of VARIVAX is unknown at present and the need for

booster doses is not defined. However, a boost in antibody levels has been

observed in vaccinees following exposure to natural varicella as well as

following a booster dose of VARIVAX administered four to six years

postvaccination.

In a highly vaccinated population, immunity for some individuals may wane

due to lack of exposure to natural varicella as a result of shifting

epidemiology. Post-marketing surveillance studies are ongoing to evaluate

the need and timing for booster vaccination.

Vaccination with VARIVAX may not result in protection of all healthy,

susceptible children, adolescents, and adults (see CLINICAL PHARMACOLOGY ).

(back to top)

CONTRAINDICATIONS

A history of hypersensitivity to any component of the vaccine, including

gelatin.

A history of anaphylactoid reaction to neomycin (each dose of reconstituted

vaccine contains trace quantities of neomycin).

Individuals with blood dyscrasias, leukemia, lymphomas of any type, or other

malignant neoplasms affecting the bone marrow or lymphatic systems.

Individuals receiving immunosuppressive therapy. Individuals who are on

immunosuppressant drugs are more susceptible to infections than healthy

individuals. Vaccination with live attenuated varicella vaccine can result

in a more extensive vaccine-associated rash or disseminated disease in

individuals on immunosuppressant doses of corticosteroids.

Individuals with primary and acquired immunodeficiency states, including

those who are immunosuppressed in association with AIDS or other clinical

manifestations of infection with human immunodeficiency virus; cellular

immune deficiencies; and hypogammaglobulinemic and dysgammaglobulinemic

states.

A family history of congenital or hereditary immunodeficiency, unless the

immune competence of the potential vaccine recipient is demonstrated.

Active untreated tuberculosis.

Any febrile respiratory illness or other active febrile infection.

Pregnancy; the possible effects of the vaccine on fetal development are

unknown at this time. However, natural varicella is known to sometimes cause

fetal harm. If vaccination of postpubertal females is undertaken, pregnancy

should be avoided for three months following vaccination. (See PRECAUTIONS ,

Pregnancy ).

(back to top)

WARNINGS

Children and adolescents with acute lymphoblastic leukemia (ALL) in

remission can receive the vaccine under an investigational protocol. More

information is available by contacting the VARIVAX coordinating center,

Bio-Pharm Clinical Services, Inc., 4 Valley Square, Blue Bell, PA 19422

(215) 283-0897.

(back to top)

PRECAUTIONS

General

Adequate treatment provisions, including epinephrine injection (1:1000),

should be available for immediate use should an anaphylactoid reaction

occur.

The duration of protection from varicella infection after vaccination with

VARIVAX is unknown.

It is not known whether VARIVAX given immediately after exposure to natural

varicella virus will prevent illness.

Vaccination should be deferred for at least 5 months following blood or

plasma transfusions, or administration of immune globulin or varicella

zoster immune globulin (VZIG).

Following administration of VARIVAX, any immune globulin including VZIG

should not be given for 2 months thereafter unless its use outweighs the

benefits of vaccination.

Vaccine recipients should avoid use of salicylates for 6 weeks after

vaccination with VARIVAX as Reye's Syndrome has been reported following the

use of salicylates during natural varicella infection (see CLINICAL

PHARMACOLOGY , Reye's Syndrome ).

The safety and efficacy of VARIVAX have not been established in children and

young adults who are known to be infected with human immunodeficiency

viruses with and without evidence of immunosuppression (see also

CONTRAINDICATIONS ).

Care is to be taken by the health care provider for safe and effective use

of VARIVAX.

The health care provider should question the patient, parent, or guardian

about reactions to a previous dose of VARIVAX or a similar product.

The health care provider should obtain the previous immunization history of

the vaccinee.

VARIVAX should not be injected into a blood vessel.

Vaccination should be deferred in patients with a family history of

congenital or hereditary immunodeficiency until the patient's own immune

system has been evaluated.

A separate sterile needle and syringe should be used for administration of

each dose of VARIVAX to prevent transfer of infectious diseases.

Needles should be disposed of properly and should not be recapped.

Transmission

Post-marketing experience suggests that transmission of vaccine virus may

occur rarely between healthy vaccinees who develop a varicella-like rash and

healthy susceptible contacts. Transmission of vaccine virus from vaccinees

without a varicella-like rash has been reported but has not been confirmed.

Therefore, vaccine recipients should attempt to avoid, whenever possible,

close association with susceptible high-risk individuals for up to six

weeks. In circumstances where contact with high-risk individuals is

unavoidable, the potential risk of transmission of vaccine virus should be

weighed against the risk of acquiring and transmitting natural varicella

virus. Susceptible high-risk individuals include:

immunocompromised individuals

pregnant women without documented history of chickenpox or laboratory

evidence of prior infection

newborn infants of mothers without documented history of chickenpox or

laboratory evidence of prior infection

Information for Patients

The health care provider should inform the patient, parent or guardian of

the benefits and risks of VARIVAX.

Patients, parents, or guardians should be instructed to report any adverse

reactions to the health care provider.

The U.S. Department of Health and Human Services has established a Vaccine

Adverse Event Reporting System (VAERS) to accept all reports of suspected

adverse events after the administration of any vaccine, including but not

limited to the reporting of events required by the National Childhood

Vaccine Injury Act of 1986. The VAERS toll-free number for VAERS forms and

information is 1-800-822-7967.

Pregnancy should be avoided for three months following vaccination.

(back to top)

Drug Interactions

See PRECAUTIONS , General , regarding the administration of immune

globulins, salicylates, and transfusions.

Drug Interactions, Use with Other Vaccines

Results from clinical studies indicate that VARIVAX can be administered

concomitantly with M-M-R II (Measles, Mumps, and Rubella Virus Vaccine

Live).

Limited data from an experimental product containing varicella vaccine

suggest that VARIVAX can be administered concomitantly with DTaP

(diphtheria, tetanus, acellular pertussis) and PedvaxHIB using separate

sites and syringes (see CLINICAL PHARMACOLOGY , Studies with Other

Vaccines ). However, there are no data relating to simultaneous

administration of VARIVAX with DTP or OPV.

Carcinogenesis, Mutagenesis, Impairment of Fertility

VARIVAX has not been evaluated for its carcinogenic or mutagenic potential,

or its potential to impair fertility.

Pregnancy

Pregnancy Category C: Animal reproduction studies have not been conducted

with VARIVAX. It is also not known whether VARIVAX can cause fetal harm when

administered to a pregnant woman or can affect reproduction capacity.

Therefore, VARIVAX should not be administered to pregnant females;

furthermore, pregnancy should be avoided for three months following

vaccination (see CONTRAINDICATIONS ).

Nursing Mothers

It is not known whether varicella vaccine virus is secreted in human milk.

Therefore, because some viruses are secreted in human milk, caution should

be exercised if VARIVAX is administered to a nursing woman.

Pediatric Use

No clinical data are available on safety or efficacy of VARIVAX in children

less than one year of age and administration to infants under twelve months

of age is not recommended.

(back to top)

ADVERSE REACTIONS

In clinical trials, VARIVAX was administered to 11,102 healthy children,

adolescents, and adults. VARIVAX was generally well tolerated.

In a double-blind placebo controlled study among 914 healthy children and

adolescents who were serologically confirmed to be susceptible to varicella,

the only adverse reactions that occurred at a significantly (p<0.05) greater

rate in vaccine recipients than in placebo recipients were pain and redness

at the injection site.

Children 1 to 12 Years of Age

In clinical trials involving healthy children monitored for up to 42 days

after a single dose of VARIVAX, the frequency of fever, injection-site

complaints, or rashes were reported as follows:

Table 1

Fever, Local Reactions, or Rashes (%) in Children

0 to 42 Days Postvaccination Reaction N Post dose 1 Peak Occurrence in

Postvaccination Days

Fever >/=102°F (39°C) Oral

8827 14.7% 0-42

Injection-site complaints (pain/soreness,

swelling and/or erythema, rash, pruritus,

hematoma, induration, stiffness) 8916 19.3% 0-2

Varicella-like rash (injection site)

Median number of lesions 8916 3.4%

2 8-19

Varicella-like rash (generalized)

Median number of lesions 8916 3.8%

5 5-26

In addition, the most frequently (>/=1%) reported adverse experiences,

without regard to causality, are listed in decreasing order of frequency:

upper respiratory illness, cough, irritability/nervousness, fatigue,

disturbed sleep, diarrhea, loss of appetite, vomiting, otitis, diaper

rash/contact rash, headache, teething, malaise, abdominal pain, other rash,

nausea, eye complaints, chills, lymphadenopathy, myalgia, lower respiratory

illness, allergic reactions (including allergic rash, hives), stiff neck,

heat rash/prickly heat, arthralgia, eczema/dry skin/dermatitis,

constipation, itching.

Pneumonitis has been reported rarely (<1%) in children vaccinated with

VARIVAX; a causal relationship has not been established.

Febrile seizures have occurred rarely (<0.1%) in children vaccinated with

VARIVAX; a causal relationship has not been established.

Adolescents and Adults 13 Years of Age and Older

In clinical trials involving healthy adolescents and adults, the majority of

whom received two doses of VARIVAX and were monitored for up to 42 days

after any dose, the frequency of fever, injection-site complaints, or rashes

were reported as follows:

Table 2

Fever, Local Reactions, or Rashes (%) in Adolescents and Adults

0 to 42 Days Postvaccination Reaction N Post

Dose 1 Peak Occurrence

in

Postvaccination Days N Post

Dose 2 Peak Occurrence

in

Postvaccination Days

Fever >/=100°F (37.7°C)

Oral 1584 10.2% 14-27 956 9.5% 0-42

Injection-site complaints

(soreness, erythema, swelling, rash,

pruritus, pyrexia, ematoma,

induration, numbness) 1606 24.4% 0-2 955 32.5% 0-2

Varicella-like rash (injection site)

Median number of lesions 1606 3%

2 6-20 955 1%

2 0-6

Varicella-like rash (generalized)

Median number of lesions 1606 5.5%

5 7-21 955 0.9%

5.5 0-23

In addition, the most frequently (>/=1%) reported adverse experiences,

without regard to causality, are listed in decreasing order of frequency:

upper respiratory illness, headache, fatigue, cough, myalgia, disturbed

sleep, nausea, malaise, diarrhea, stiff neck, irritability/nervousness,

lymphadenopathy, chills, eye complaints, abdominal pain, loss of appetite,

arthralgia, otitis, itching, vomiting, other rashes, constipation, lower

respiratory illness, allergic reactions (including allergic rash, hives),

contact rash, cold/canker sore.

As with any vaccine, there is the possibility that broad use of the vaccine

could reveal adverse reactions not observed in clinical trials.

The following additional adverse reactions have been reported since the

vaccine has been marketed:

Body As A Whole

Anaphylaxis.

Hemic and Lymphatic System

Thrombocytopenia.

Nervous/Psychiatric

Encephalitis; Guillain-Barré syndrome; transverse myelitis;

Bell's palsy; ataxia; paresthesia.

Respiratory

Pharyngitis.

Skin

s- syndrome; erythema multiforme; Henoch-Schönlein purpura;

secondary bacterial infections of skin and soft tissue, including impetigo

and cellulitis; herpes zoster.

(back to top)

DOSAGE AND ADMINISTRATION

FOR SUBCUTANEOUS ADMINISTRATION

Do not inject intravenously

Children 12 months to 12 years of age should receive a single 0.5 mL dose

administered subcutaneously.

Adolescents and adults 13 years of age and older should receive a 0.5 mL

dose administered subcutaneously at elected date and a second 0.5 mL dose 4

to 8 weeks later.

VARIVAX is for subcutaneous administration. The outer aspect of the upper

arm (deltoid) is the preferred site of injection.

VARIVAX SHOULD BE STORED FROZEN at an average temperature of -15°C (+5°F) or

colder until it is reconstituted for injection (see HOW SUPPLIED ,

Storage ). Any freezer (e.g. chest, frost-free) that reliably maintains an

average temperature of -15°C and has a separate sealed freezer door is

acceptable for storing VARIVAX. The diluent should be stored separately at

room temperature or in the refrigerator. To reconstitute the vaccine, first

withdraw 0.7 mL of diluent into the syringe to be used for reconstitution.

Inject all the diluent in the syringe into the vial of lyophilized vaccine

and gently agitate to mix thoroughly. Withdraw the entire contents into a

syringe and inject the total volume (about 0.5 mL) of reconstituted vaccine

subcutaneously, preferably into the outer aspect of the upper arm (deltoid)

or the anterolateral thigh. IT IS RECOMMENDED THAT THE VACCINE BE

ADMINISTERED IMMEDIATELY AFTER RECONSTITUTION, TO MINIMIZE LOSS OF POTENCY.

DISCARD IF RECONSTITUTED VACCINE IS NOT USED WITHIN 30 MINUTES.

CAUTION : A sterile syringe free of preservatives, antiseptics, and

detergents should be used for each injection and/or reconstitution of

VARIVAX because these substances may inactivate the vaccine virus.

It is important to use a separate sterile syringe and needle for each

patient to prevent transmission of infectious agents from one individual to

another.

To reconstitute the vaccine, use only the Merck sterile diluent supplied

with VARIVAX, M-M-R II, or the component vaccines of M-M-R II, since it is

free of preservatives or other anti-viral substances which might inactivate

the vaccine virus.

Do not freeze reconstituted vaccine.

Do not give immune globulin including Varicella Zoster Immune Globulin

concurrently with VARIVAX (see also PRECAUTIONS ).

Parenteral drug products should be inspected visually for particulate matter

and discoloration prior to administration, whenever solution and container

permit. VARIVAX when reconstituted is a clear, colorless to pale yellow

liquid.

(back to top)

HOW SUPPLIED

No. 4826/4309--VARIVAX is supplied as follows: (1) a single-dose vial of

lyophilized vaccine, NDC 0006-4826-00 (package A); and (2) a box of 10 vials

of diluent (package .

No. 4827/4309--VARIVAX is supplied as follows: (1) a box of 10 single-dose

vials of lyophilized vaccine (package A), NDC 0006-4827-00; and (2) a box of

10 vials of diluent (package

(6505-01-413-1331, Ten Pack).

Stability

VARIVAX retains a potency level of 1500 PFU or higher per dose for at least

18 months in a frost-free freezer with an average temperature of -15°C

(+5°F) or colder.

VARIVAX has a minimum potency level of approximately 1350 PFU 30 minutes

after reconstitution at room temperature (20-25°C, 68-77°F).

Prior to reconstitution, VARIVAX retains potency when stored for up to 72

continuous hours at refrigerator temperature (2-8°C, 36-46°F).

For information regarding stability under conditions other than those

recommended, call 1-800-9-VARIVAX.

Storage

During shipment, to ensure that there is no loss of potency, the vaccine

must be maintained at a temperature of -20°C (-4°F) or colder.

Before reconstitution, store the lyophilized vaccine in a freezer at an

average temperature of -15°C (+5°F) or colder. Any freezer (e.g. chest,

frost-free) that reliably maintains an average temperature of -15°C and has

a separate sealed freezer door is acceptable for storing VARIVAX.

VARIVAX may be stored at refrigerator temperature (2-8°C, 36-46°F) for up to

72 continuous hours prior to reconstitution. Vaccine stored at 2-8°C which

is not used within 72 hours of removal from -15°C storage should be

discarded.

Before reconstitution, protect from light.

The diluent should be stored separately at room temperature (20-25°C,

68-77°F), or in the refrigerator.

7999907 Issued March 1998

Copyright © MERCK & CO., Inc., 1995

All rights reserved

Stedman's Definition

Enter a word or phrase to search for. (HINT: Highlight a word with the mouse

and use copy and paste)

Home Site Map FAQ Help Register Search

Copyright © 2000 by Medical Economics Company, Inc. at Montvale, NJ 07645.

All rights reserved.

Use of PDR.net subject to license agreement.

Click here to read our disclaimer or privacy policy.

----------------------------------------------------------------------------

----

Re: Chickenpox Vaccination

>

> --- JustMOMThanks@... wrote:

> > Here is my personal take on the chicken pox vaccine.

> > Chicken pox is not the

> > biggest of things for a parent to worry about. They

> > are little, red, itchy

> > bumps that annoy the heck out of your child. Sure,

> > they are highly

> > contagious...but so what? So is the common cold. I

> > think it's just another

> > useless vaccine. Besides, there hasn't been any

> > actual proof that the

> > children given this vaccine won't get the chicken

> > pox later in life...when it

> > becomes shingles. I'd rather have my kid get

> > chicken pox when someone at

> > school has than have my son or daughter get shingles

> > at 35 or 40. That's

> > just my opinion. The only vaccines my daughter is

> > receiving are the MMR,

> > Polio, and DTP. She won't be getting her booster

> > MMR but she will receive

> > the booster Tetanus. But, that's me. At any rate,

> > do more research before

> > you commit...that's always the best answer.

> >

> > Jo

>

> Hi Jo,

>

> Thanks so much for your reply! I pretty much agree

> with you on the chickenpox vaccination but this is the

> reason I think my child should get it. My child just

> turned 13 and has never had the chickenpox. They say

> that after 12 if you child hasn't had it naturally,

> that's when they enter the age where getting

> chickenpox can be very serious. I've read that now in

> two places. That scares me! So I don't know what to

> do. My md encourages my child to get it, for whatever

> that is worth. I tend to agree with you that it is

> just another useless vaccination especially when I

> found out it was originally developed for children

> with leukemina (sp?) and problems with immune system.

> If chickenpox was such a bad thing then why wasn't the

> shot developed for everyone. You know what I'm

> saying. Did you find any useful information on this

> shot that helped you to come to you decision. Please

> let me know.

>

> Thanks,

>

> Gail

> >

>

>

> __________________________________________________

>

[Guest guest]

hi gail,

first thing i'd like to say is that this vax is way too new to trust it--you

don't want your kid to be a guinea(sp?) pig for something as common as

chicken pox. even the phamphlet the ped. hands out, states that the main

reason to vax for this illness is for convenience. but my own personal

experience is that at the age of 34, my 5 year old got them and when he was

getting better, i got them for the first time in my life. i have 6 brothers

and sisters and only 2 of them (besides myself now) ever got them & they got

them as kids. i had been exposed many times as a child and several times as

an adult--i always figured i was immune to them--never worried about being

around infected people. now i know for sure i don't have to worry about

them!! as far as them being worse, because i was an adult, i dunno? they

were pretty bad, bad fever for a day or two, but i survived just

fine--without any chemical interventions. i would try not to worry too much,

just let nature run it's course. i still have 4 brothers & sisters who are

all in their 30's & 40's, all with kids of their own and they still haven't

had them--i'd hate to see you vax your daughter for a very common, rarely

complicated disease that she may never get anyway. anyway, just my

opinion--good luck to you,

brigit

[Guest guest]

Everyone in my family was in there 20's when we got them -even after

repeated exposures.(good immune systems). They were bad, but I'd still

rather get them naturally.

[Guest guest]

In a message dated 05-18-00 1:50:44 PM Central Daylight Time,

purpleturtle51@... writes:

<< but this is the

reason I think my child should get it. My child just

turned 13 and has never had the chickenpox. They say

that after 12 if you child hasn't had it naturally, >>

Gail,

Do you realize that the chicken pox vaccine is made from 2 aborted babies?

That reason alone is enough for me to NEVER get it.. I would rather a child

get it at 13-17 than at 25.

Have a blessed weekend!

In Christ,

Kim

[Guest guest]

--- beebemcel@... wrote:

> hi gail,

> first thing i'd like to say is that this vax is way

> too new to trust it--you

> don't want your kid to be a guinea(sp?) pig for

> something as common as

> chicken pox. even the phamphlet the ped. hands out,

> states that the main

> reason to vax for this illness is for convenience.

> but my own personal

> experience is that at the age of 34, my 5 year old

> got them and when he was

> getting better, i got them for the first time in my

> life. i have 6 brothers

> and sisters and only 2 of them (besides myself now)

> ever got them & they got

> them as kids. i had been exposed many times as a

> child and several times as

> an adult--i always figured i was immune to

> them--never worried about being

> around infected people. now i know for sure i don't

> have to worry about

> them!! as far as them being worse, because i was an

> adult, i dunno? they

> were pretty bad, bad fever for a day or two, but i

> survived just

> fine--without any chemical interventions. i would

> try not to worry too much,

> just let nature run it's course. i still have 4

> brothers & sisters who are

> all in their 30's & 40's, all with kids of their own

> and they still haven't

> had them--i'd hate to see you vax your daughter for

> a very common, rarely

> complicated disease that she may never get anyway.

> anyway, just my

> opinion--good luck to you,

> brigit

Hi Brigit,

Thanks for your reply. You made some good points and

made me feel better about it! How long do you think a

vaccination needs to be out to prove itself? I've

heard a generation. I think that's ridiculous to have

a vaccination for the convenience of everyone! That's

absurd especially when you don't even know how you

will react to a vaccination.

Write back if you feel like it.

Thanks,

Gail

>

__________________________________________________

[Guest guest]

--- & Troy Lucas <lucasjt@...> wrote:

> Everyone in my family was in there 20's when we got

> them -even after

> repeated exposures.(good immune systems). They were

> bad, but I'd still

> rather get them naturally.

>

>

Hi ,

Thanks for the information and the reply to my e-mail.

Gail

>

__________________________________________________

[Guest guest]

gail,

as far as how long does a vax need to be out ot prove itself? well, i'm not

the one to ask, for two reasons; one, i have no " real " knowledge of these

things and two; i personally don't think vaxes ever " prove " themselves. but,

i would say that i feel the longer we use them, the worse things get because,

the more generations of vaxed individuals we have out there, the more poeple

we have without real immunity to these diseases and the more susceptible

they, and their offspring will become. just an idea, but seems this way to

me. i have always felt that the more you can get theu on your own naturally,

the better off you are and the healthier your children will be. i also worry

what shape the future children, of these last few vaxed generations, will be

in, now that we have vaxed parents, having vaxed babies and now those babies

are getting old enough to have vaxed babies--the idea of compounding all

these vaccines genreation after generation bothers me. anyway, certainly

doesn't seem worth the risk as far as chickenpox goes.

also, remember, once someone has a vax, you can't take it back. i also think

they will be offering a booster for chicken pox vax in the future, as we will

now have an entire generation of adults who are susceptible to the disease

because they never got it as kids and their vax has worn off. just not a

good idea. again, just my opinion, hope it helps. take care,

brigit

[Guest guest]

Interesting how so much fear has been put into diseases because of

drug companies. When I was young (now almost 44) I got chicken pox

(around age 14) and everyone in town brought their child over to

catch it. That is what I remember about childhood diseases. When one

child caught something - off we'd go to their home to share :-)

Supressive medicine seems to be of the impression that diseases are

bad for the body. On the contrary - the human body was MADE to get

ill. It makes us stronger. If it were my child I'd be out there

looking for a child who has chicken pox so they could share.

--

Bethanne Elion Volhard list moderator (volhard-subscribeegroups)

http://www.barkingbear.com knitnewf@...

[Guest guest]

I am 27 years old and have never had the chicken pox. I have been around it

several times in my life and never caught it. (The wonders of natural

immunity). I have been asked by my doc to get the vax, but I too refuse. I

feel that if I were to get it in the future, I'd just have to deal with it

then.

Diane

Re: Chickenpox Vaccination

>In a message dated 05-18-00 1:50:44 PM Central Daylight Time,

>purpleturtle51@... writes:

>

><< but this is the

> reason I think my child should get it. My child just

> turned 13 and has never had the chickenpox. They say

> that after 12 if you child hasn't had it naturally, >>

>Gail,

>

>Do you realize that the chicken pox vaccine is made from 2 aborted babies?

>That reason alone is enough for me to NEVER get it.. I would rather a child

>get it at 13-17 than at 25.

>

>Have a blessed weekend!

>

>In Christ,

>Kim

>

>------------------------------------------------------------------------

>Up to 60% OFF food!

>Buy Now and Shipping is Free.

>1/4016/7/_/489317/_/958710356/

>------------------------------------------------------------------------

>

>

>

[Guest guest]

--- Bethanne Elion <knitnewf@...> wrote:

>

> Interesting how so much fear has been put into

> diseases because of

> drug companies. When I was young (now almost 44) I

> got chicken pox

> (around age 14) and everyone in town brought their

> child over to

> catch it. That is what I remember about childhood

> diseases. When one

> child caught something - off we'd go to their home

> to share :-)

> Supressive medicine seems to be of the impression

> that diseases are

> bad for the body. On the contrary - the human body

> was MADE to get

> ill. It makes us stronger. If it were my child I'd

> be out there

> looking for a child who has chicken pox so they

> could share.

>

> --

> Bethanne Elion Volhard list moderator

> (volhard-subscribeegroups)

> http://www.barkingbear.com knitnewf@...

Hello Everyone,

Thanks to all who sent me an e-mail in response to my

inquiry on the chickenpox vaccination. They were all

appreciated.

Thanks again,

Gail

>

__________________________________________________

[Guest guest]

Let your hcildren get chicken pox! Your son very likely would get

chickenpox FROM the vaccine anyway.

There are homeopathic options to help with chickenpox.

NO VACCINES.....no it doesn't contain thimerosal, but it could PUSH HIM

OVER THE BRINK

At 01:35 PM 01/04/2003 -0000, you wrote:

>There have been 2 cases of chickenpox in my son's school in the past

>2 or 3 days.

>

>Is it safe to vaccinate my son for it? I know its not a good idea,

>but I'm quite scared in case it spreads to the other children. Does

>this vaccine contain thimerosol?

>

>My son wouldn't listen if I ask him not to scratch his skin causing

>further problems, which is why I'm worried about what to do.

>

>Any ideas/suggestions please? Should I get him vaccinated for it?

>

>Thanks a lot

>

>

>

>=======================================================

>

[Guest guest]

Let her get the pox. It's not that big of a deal. My daughter got it last year

at this time, and I couldn't believe how untraumatic it was. She ran a slight

fever, had a bunch of spots everywhere, laid on the couch for a few days, and

took oatmeal bathes! It was no big deal. When she got itchy, I gave her a low

dose of Benadryl and she never even scratched. My boys never got it, because

they were vaccinated. I wish I hadn't done that to them. My best friend

brought her daughter over to play so she would catch it. She did, and again, no

big deal.

If you vaccinate your daughter you are pushing the odds that she will get the

pox as an older child or adult, when it can be more serious. Don't do it. That

vaccine is a joke, and offers very poor immunity.

a

[Guest guest]

,

I believe the HV6 virus, chicken pox vaccine caused my son's autism

and also his brain tumor. This is one vaccine I would stay far away

from. The exposure your child would get from a child from school

would be so minimal, no need to inject any toxins into your child. I

believe the old fashion way of acquiring viruses is much safer.

nne

> There have been 2 cases of chickenpox in my son's school in the

past

> 2 or 3 days.

>

> Is it safe to vaccinate my son for it? I know its not a good idea,

> but I'm quite scared in case it spreads to the other children. Does

> this vaccine contain thimerosol?

>

> My son wouldn't listen if I ask him not to scratch his skin causing

> further problems, which is why I'm worried about what to do.

>

> Any ideas/suggestions please? Should I get him vaccinated for it?

>

> Thanks a lot

>

[Guest guest]

>

>

>

>Message: 9

> Date: Sat, 04 Jan 2003 14:16:08 +0000

> From: Sheri Nakken <vaccineinfo@...>

>Subject: Re: Chickenpox vaccination

>

>Let your hcildren get chicken pox! Your son very likely would get

>chickenpox FROM the vaccine anyway.

>

>There are homeopathic options to help with chickenpox.

>

>NO VACCINES.....no it doesn't contain thimerosal, but it could PUSH HIM

>OVER THE BRINK

>

>At 01:35 PM 01/04/2003 -0000, you wrote:

>

>

>>There have been 2 cases of chickenpox in my son's school in the past

>>2 or 3 days.

>>

>>Is it safe to vaccinate my son for it? I know its not a good idea,

>>but I'm quite scared in case it spreads to the other children. Does

>>this vaccine contain thimerosol?

>>

>>My son wouldn't listen if I ask him not to scratch his skin causing

>>further problems, which is why I'm worried about what to do.

>>

>>Any ideas/suggestions please? Should I get him vaccinated for it?

>>

>>Thanks a lot

>>

>>

>>

Ill back Sherri up on that 100%

Chicken Pox isnt great (I had it 2x as a child) but the way the vaccine

is made and what it does is questionable.

Read for yourself the indications and warnings from Merck

http://66.70.140.217/a/pdf/varivax_pi.pdf

It advises staying away from salicylites after getting it for weeks. It

is also cultured on human diploid cells (Merck states this in the first

paragraph) which where likely derived from aborted fetal tissue (a

detail merck doesnt mention).

[Guest guest]

>Chicken Pox isnt great (I had it 2x as a child) but the way the vaccine

>is made and what it does is questionable.

>

>Read for yourself the indications and warnings from Merck

>http://66.70.140.217/a/pdf/varivax_pi.pdf

>

>It advises staying away from salicylites after getting it for weeks. It

>is also cultured on human diploid cells (Merck states this in the first

>paragraph) which where likely derived from aborted fetal tissue (a

>detail merck doesnt mention).

>

>

Most definitely grown on aborted fetal tissue - right in the package insert

I will suggest to you that vaccines don't work - they don't give you

immunity. The introduce these substances into you and then your body

fights them forever with NO outlet - the rash is how these diseases leave

your bodies. No rash, no leave. That is why such high titres in many

from vaccines - ie measles titres, etc. They go around and around. WE

always knew that if a rash was slow to come out in measles, brain

damage/encephalitis could result. Voila, vaccinate, rash never comes out,

brain damage in many. Its very simple.

The reason some don't get the disease after the vaccine (and you assume the

vaccine 'works') is because you have been given a chronic case of hte

disease - subliminal - and you can't get an acute case. I hope this make

sense. If you are too ill fighting something, you rarely will get anything

acute. You do NOT get immunity from ANY vaccine ever. Antibody levels

don't mean immunity - they mean exposure - they are just ONE part of the

immune system.

Please, everyone, you need to educate yourselves even further beyond

MERCURY - it is about more than mercury (although mercury is horrendous)

DESCRIPTION:

Varivax (Varicella Vaccine) is a preparation of the Oka/Merck strain of

live attenuated

varicella virus. The virus was initially obtained from a child with natural

varicella, then

introduced into human embryonic lung cell cultures, adapted to and

propagated in

embryonic guinea pig cell cultures and finally propagated in human diploid

cell cultures

(WI-38). Further passage of the virus for varicella vaccine was performed

at Merck

Research Laboratories (MRL) in human diploid cell cultures (MRC-5) that

were free of

adventitious agents. This live, attenuated varicella vaccine is a

lyophilized preparation

containing sucrose, phosphate, glutamate, and processed gelatin as

stabilizers.

--------------------------------------------------------

Sheri Nakken, R.N., MA

Vaccination Information & Choice Network, Nevada City CA & Wales UK

$$ Donations to help in the work - accepted by Paypal account

vaccineinfo@... voicemail US 530-740-0561

(go to http://www.paypal.com) or by mail

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm

Homeopathy course - http://www.nccn.net/~wwithin/homeo.htm

ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL

OR LEGAL ADVICE. THE

DECISION TO VACCINATE IS YOURS AND YOURS ALONE.

******

" Just look at us. Everything is backwards; everything is upside down.

Doctors destroy health, lawyers destroy justice, universities destroy

knowledge, governments destroy freedom, the major media destroy information

and religions destroy spirituality " .... Ellner

[Guest guest]

Sherri-Tell us more!Your sharing is great info and I for one pass it on to many

people .

Thanks, R

[Guest guest]

I am debating this one right now myself, although for my little guy

who is 14mo. I really don't want him getting c/p since it can be

nasty. My 8yr old (autistic) had the c/p vacc and it did work well

to prevent it since her school had 2 outbreaks (1 in k'garten and 1

in first grade) she never got it although some kids who had gotten

the vaccine did get a mild case. I don't know about if your son has

already been exposed-might ask your ped about that. It does not

contain Thimerosol, but if the son you are referring to is autistic,

you might want to really consider the immune system effect. I don't

think any shots at this point are such a great idea for my daughter.

This was probably no help at all lol. Everyone has different views

about all this and its really a very personal choice for you based on

your own beliefs, intuition, how your son has reacted to vaccines in

the past, etc. If you go ahead, good idea to give him vit C for a few

days prior. Good luck!

> There have been 2 cases of chickenpox in my son's school in the

past

> 2 or 3 days.

>

> Is it safe to vaccinate my son for it? I know its not a good idea,

> but I'm quite scared in case it spreads to the other children. Does

> this vaccine contain thimerosol?

>

> My son wouldn't listen if I ask him not to scratch his skin causing

> further problems, which is why I'm worried about what to do.

>

> Any ideas/suggestions please? Should I get him vaccinated for it?

>

> Thanks a lot

>

[Guest guest]

In a message dated 04/01/2003 18:42:26 GMT Standard Time,

vaccineinfo@... writes:

> Chicken Pox isnt great (I had it 2x as a child) but the way the vaccine

> >is made and what it does is questionable.

> >

> >Read for yourself the indications and warnings from Merck

> >http://66.70.140.217/a/pdf/varivax_pi.pdf

> >

> >It advises staying away from salicylites after getting it for weeks. It

> >is also cultured on human diploid cells (Merck states this in the first

> >paragraph) which where likely derived from aborted fetal tissue (a

> >detail merck doesnt mention).

> >

> >

>

> Most definitely grown on aborted fetal tissue - right in the package insert

> I will suggest to you that vaccines don't work - they don't give you

> immunity. The introduce these substances into you and then your body

> fights them forever with NO outlet - the rash is how these diseases leave

> your bodies. No rash, no leave. That is why such high titres in many

> from vaccines - ie measles titres, etc. They go around and around. WE

> always knew that if a rash was slow to come out in measles, brain

> damage/encephalitis could result. Voila, vaccinate, rash never comes out,

> brain damage in many. Its very simple.

>

> The reason some don't get the disease after the vaccine (and you assume the

> vaccine 'works') is because you have been given a chronic case of hte

> disease - subliminal - and you can't get an acute case. I hope this make

> sense. If you are too ill fighting something, you rarely will get anything

> acute. You do NOT get immunity from ANY vaccine ever. Antibody levels

> don't mean immunity - they mean exposure - they are just ONE part of the

> immune system.

>

> Please, everyone, you need to educate yourselves even further beyond

> MERCURY - it is about more than mercury (although mercury is horrendous)

>

> DESCRIPTION:

>

> Varivax (Varicella Vaccine) is a preparation of the Oka/Merck strain of

> live attenuated

> varicella virus. The virus was initially obtained from a child with natural

> varicella, then

> introduced into human embryonic lung cell cultures, adapted to and

> propagated in

> embryonic guinea pig cell cultures and finally propagated in human diploid

> cell cultures

> (WI-38). Further passage of the virus for varicella vaccine was performed

> at Merck

> Research Laboratories (MRL) in human diploid cell cultures (MRC-5) that

> were free of

> adventitious agents. This live, attenuated varicella vaccine is a

> lyophilized preparation

> containing sucrose, phosphate, glutamate, and processed gelatin as

> stabilizers.

>

> --------------------------------------------------------

> Sheri Nakken, R.N., MA

>

[Guest guest]

> Is it safe to vaccinate my son for it?

Depends on your child and who you ask. It does actually CAUSE the

disease in a good percentage of children, sometimes a mild case,

sometimes severe/shingles. And it also does not confer full immunity,

requiring multiple boosters.

If your child is high metals, then you should not allow any

vaccinations, even if they do not contain thimerosal, until your

child's metal levels are reduced.

I know its not a good idea,

> but I'm quite scared in case it spreads to the other children. Does

> this vaccine contain thimerosol?

No, but it might contain aluminum, phenol, formaldehyde, or other

preservative. You can check here if you want to find out

http://www.whale.to/vaccines.html

> Any ideas/suggestions please? Should I get him vaccinated for it?

If you believe it is a good idea, then you should. But be prepared

that it has a good chance of causing the disease as well as preventing

it. So long as you are aware of potential issues, and still believe

it is best for your child, then you should.

Dana

[Guest guest]

,

My son regressed after the chickenpox vaccine and I regret letting him get it.

I think it would be better for his immune system if your son got it naturally,

but the scratching is an issue.

Good luck,

kathy

Chickenpox vaccination

There have been 2 cases of chickenpox in my son's school in the past

2 or 3 days.

Is it safe to vaccinate my son for it? I know its not a good idea,

but I'm quite scared in case it spreads to the other children. Does

this vaccine contain thimerosol?

My son wouldn't listen if I ask him not to scratch his skin causing

further problems, which is why I'm worried about what to do.

Any ideas/suggestions please? Should I get him vaccinated for it?

Thanks a lot

[Guest guest]

It's, of course, the parent's decision either way you go, but I'll

tell you that the chicken pox vacc is one of the one's I regret the

most. Tom was already regressing by the time the ped. talked me into

giving him this brand new shot (I was pregnant at the time, and he

scared me into it- " if Tom gets chicken pox, your new baby may get it

and die " , blah blah blah). Anyway, Tom had a *horrible* reaction

that lasted weeks and weeks. I have often suspected some type of

ongoing reaction to that shot. We're seeing some nice things with

lauricidin right now, so maybe it is beating back some kind of

ongoing herpes virus - who knows!

Just our experience. Good luck with your decision.

Peace and grace,

Sally, mom to

Tom, 8yo dx AS but on the road to recovery

Ben, 5yo NT by the grace of God

Gracie, 2yo NT and unvaccinated

[Guest guest]

A BIG thanks to everyone who replied to my post. I'm so glad I asked

the group before I took the decision.

Now, after reading all your posts, I've decided NOT to get him

vaccinated for chicken pox. I didn't know that there are so many

negatives to it. I wonder what kind of damage I would have caused had

I gone ahead with it.

Thanks once again

> In a message dated 1/4/2003 10:16:27 AM Eastern Standard Time,

> marib005@h... writes:

>

> > I believe the HV6 virus, chicken pox vaccine caused my son's

autism

>

> I thought they were two separate virus, are they one and the same?

>

>

>